Novo Site in China Gets Government Call Amid Pharma Scrutiny
This article is for subscribers only.
Novo Nordisk A/S said Chinese authorities visited one of its sites as the government extends its scrutiny of drugmakers’ local practices.
Local administrative officers stopped by a Novo factory in Tianjin, in northern China, on Aug. 1, the company said today.